FDA Announces Complete Ban of Red Dye No. 3 in Food and Drugs Due to Cancer Risk
核心洞察
The FDA has issued a comprehensive ban on FD&C Red No. 3 in food and ingested drugs, with phase-out deadlines set for January 2027 for food products and January 2028 for pharmaceuticals.
The decision follows decades of scientific evidence and advocacy, including studies showing cancer (搜索) risks in male rats at high doses, leading to the dye's presence in over 9,200 products being questioned.
The regulatory action aligns with international standards, as the synthetic dye is already banned or restricted in Australia, Japan, and the European Union, reflecting a global shift toward stricter food and drug safety measures.
The U.S. Food and Drug Administration has announced a sweeping ban on FD&C Red No. 3 (erythrosine (搜索)) in food products and ingested drugs, marking a significant shift in regulatory oversight of synthetic food additives. The decision, announced on January 15, 2025, establishes a complete phase-out timeline, with food products to eliminate the dye by January 15, 2027, and ingested drugs by January 18, 2028.
Scientific Evidence and Regulatory Background
The ban stems from the Delaney Clause of the Federal Food, Drug, and Cosmetic Act, which prohibits the FDA from approving additives linked to cancer (搜索) in humans or animals. While Red Dye No. 3 (搜索) has been deemed safe at current consumption levels, research conducted on male rats demonstrated cancer risks at high doses. This evidence led to its prohibition in cosmetics in 1990, though it remained approved for food and pharmaceutical use due to resource limitations.
Widespread Industry Impact
The synthetic dye, first approved in 1907, has become ubiquitous in the food and pharmaceutical industries, with current estimates showing its presence in more than 9,200 products. The Center for Science in the Public Interest (搜索) (CSPI) played a crucial role in advancing the ban through their 2022 petition, which emphasized the unnecessary health risks posed by the continued use of the additive.
International Alignment and Industry Response
The FDA's decision brings U.S. regulations in line with international standards, as countries including Australia, Japan, and European Union member states have already implemented bans or severe restrictions on Red Dye No. 3 (搜索). Industry stakeholders are now faced with a significant reformulation challenge during the transition period.
"Revoking the authorized use of Red No. 3 is an example of the FDA using its risk and science-based authority to review the safety of products in the marketplace," stated Sarah Gallo, senior vice president of product policy and federal, emphasizing the industry's commitment to following scientific evidence and safety regulations.
Implementation and Future Implications
The multi-year transition period provides manufacturers time to reformulate their products while maintaining compliance with FDA regulations. This regulatory action represents a crucial step in eliminating potentially harmful additives from the food and drug supply chain, setting a precedent for future safety evaluations of synthetic additives in pharmaceuticals and food products.